Evidence map›Paper›PMID 24127591›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2013

Chromatin stretch enhancer states drive cell-specific gene regulation and harbor human disease risk variants.

Stephen C J Parker, Michael L Stitzel, D Leland Taylor, Jose Miguel Orozco, Michael R Erdos, Jennifer A Akiyama, Kelly Lammerts van Bueren, Peter S Chines, Narisu Narisu, NISC Comparative Sequencing Program and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 443 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
443citing papers in PubMed, 2 pooled it
25.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

443 citing papers in PubMed, 2 syntheses or guidelines pooled it, 737 citations in OpenAlex.

  1. HGG advances · 2023
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Synthetic Regulatory Genomics.Annual review of genomics and human genetics · 2026
    Review
  6. Integrative Clinical and Functional Characterization of theDiagnostics (Basel, Switzerland) · 2026
    Article
  7. Locus-Scale Massively Parallel Reporter Assays.bioRxiv : the preprint server for biology · 2026
    Article
  8. Article
  9. Article
  10. Med14 phosphorylation shapes genomic response to GLP-1 agonists.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review

383 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Stephen C J ParkerNational Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892.
Michael L Stitzel
D Leland Taylor
Jose Miguel Orozco
Michael R Erdos
Jennifer A Akiyama
Kelly Lammerts van Bueren
Peter S Chines
Narisu Narisu
NISC Comparative Sequencing Program
Brian L Black
Axel Visel
Len A Pennacchio
Francis S Collins
National Institutes of Health Intramural Sequencing Center Comparative Sequencing Program Authors
NISC Comparative Sequencing Program Authors
National Institutes of Health · USLawrence Berkeley National Laboratory · USUniversity of California, San Francisco · US

Funding

Inter- and Intra-Species Comparative SequencingZIBHG000196 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI THOMAS, JAMES · 2009 to 2025
$177.6M
Genetic analysis of type II diabetes in Finnish populationZIAHG000024 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI ERDOS, MICHAEL · 2009 to 2025
$38.2M
Generation of an In Vivo Human Genome Transcriptional Enhancer DatasetR01HG003988 · NHGRI · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI Len Alexander Pennacchio · 2006 to 2026
$24.1M
Regulation of cardiovascular transcriptionR01HL064658 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BLACK, BRIAN L · 2000 to 2019
$5.4M
Molecular and Genetic Regulation of Craniofacial DevelopmentR01DE019118 · NIDCR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BLACK, BRIAN L · 2009 to 2013
$1.9M
Investigation of noncoding variation in human pancreatic islets and their developR00DK092251 · NIDDK · JACKSON LABORATORY · PI STITZEL, MICHAEL LEE · 2014 to 2016
$794k
Intramural NIH HHS ZIA HG000024NHGRI NIH HHS R01 HG003988NHGRI NIH HHS R01HG003988NHLBI NIH HHS R01 HL064658NHLBI NIH HHS R01HL64658NIDCR NIH HHS R01 DE019118NIDCR NIH HHS R01DE019118NIDDK NIH HHS K99 DK092251NIDDK NIH HHS K99DK092251NIDDK NIH HHS K99 DK099240NIDDK NIH HHS K99DK099240NIDDK NIH HHS R00 DK092251PHS HHS 1ZIAHG000024
6 · The paper itself

Abstract

Chromatin-based functional genomic analyses and genomewide association studies (GWASs) together implicate enhancers as critical elements influencing gene expression and risk for common diseases. Here, we performed systematic chromatin and transcriptome profiling in human pancreatic islets. Integrated analysis of islet data with those from nine cell types identified specific and significant enrichment of type 2 diabetes and related quantitative trait GWAS variants in islet enhancers. Our integrated chromatin maps reveal that most enhancers are short (median = 0.8 kb). Each cell type also contains a substantial number of more extended (≥ 3 kb) enhancers. Interestingly, these stretch enhancers are often tissue-specific and overlap locus control regions, suggesting that they are important chromatin regulatory beacons. Indeed, we show that (i) tissue specificity of enhancers and nearby gene expression increase with enhancer length; (ii) neighborhoods containing stretch enhancers are enriched for important cell type-specific genes; and (iii) GWAS variants associated with traits relevant to a particular cell type are more enriched in stretch enhancers compared with short enhancers. Reporter constructs containing stretch enhancer sequences exhibited tissue-specific activity in cell culture experiments and in transgenic mice. These results suggest that stretch enhancers are critical chromatin elements for coordinating cell type-specific regulatory programs and that sequence variation in stretch enhancers affects risk of major common human diseases.

Indexed as

AnimalsCell DifferentiationChromatinChromatin ImmunoprecipitationDiabetes Mellitus, Type 2Enhancer Elements, GeneticEpigenomicsGene Expression ProfilingGene Expression RegulationGenome-Wide Association StudyHigh-Throughput Nucleotide SequencingHumansInsulin-Secreting CellsLuciferasesMiceMice, TransgenicChromatinLuciferases

Identifiers

PMID24127591
PMCPMC3816444
OpenAlexW2079407198

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.